Keywords: vernalis, enters, cancer, accord, servier, uk, neurology

Vernalis enters cancer R&D accord with Servier

Article | 28 May 2007

UK neurology specialist drugmaker Vernalis and Servier, France's largest privately-owned pharmaceutical company, have entered into a joint, three-year, oncology drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Servier

Drug Discovery

Novartis

Go to company listing